NIVEAU

Research code: NIVEAU
Research name: Optimising the outcome of elderly and ineligible patients on high-dose chemotherapy for aggressive non-Hodgkin's lymphoma at first relapse or progression by adding nivolumab to gemcitabine, oxaliplatin and rituxumab for B-NIVEAU-derived lymphoma, DSHNHL 2015-1.
Indication: lymphoma
Principal researcher: Ewa Chmielowska, MD, PhD